These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21279810)

  • 21. Clinical application neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 as indicators of inflammation persistence and acute kidney injury in children with urinary tract infection.
    Petrovic S; Bogavac-Stanojevic N; Peco-Antic A; Ivanisevic I; Kotur-Stevuljevic J; Paripovic D; Sopic M; Jelic-Ivanovic Z
    Biomed Res Int; 2013; 2013():947157. PubMed ID: 23936859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
    Cost NG; Noh PH; Devarajan P; Ivancic V; Reddy PP; Minevich E; Bennett M; Haffner C; Schulte M; DeFoor WR
    J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary biomarkers in hydronephrosis.
    Madsen MG
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention.
    Luo Q; Zhou F; Dong H; Wu L; Chai L; Lan K; Wu M
    Clin Nephrol; 2013 Feb; 79(2):85-92. PubMed ID: 23110770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children.
    Madsen MG; Nørregaard R; Palmfeldt J; Olsen LH; Frøkiær J; Jørgensen TM
    Pediatr Nephrol; 2012 Nov; 27(11):2099-2106. PubMed ID: 22710694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
    Morrissey JJ; London AN; Lambert MC; Kharasch ED
    Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
    van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
    Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age.
    Hazle MA; Gajarski RJ; Aiyagari R; Yu S; Abraham A; Donohue J; Blatt NB
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):861-867.e1. PubMed ID: 23317940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
    Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.
    Verbrugge FH; Dupont M; Shao Z; Shrestha K; Singh D; Finucan M; Mullens W; Tang WH
    J Card Fail; 2013 Sep; 19(9):621-8. PubMed ID: 24054338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Novel Biomarkers of Obstructive Nephropathy in Children with Hydronephrosis.
    Bieniaś B; Sikora P
    Dis Markers; 2018; 2018():1015726. PubMed ID: 30327688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery.
    Cantinotti M; Storti S; Lorenzoni V; Arcieri L; Moschetti R; Murzi B; Spadoni I; Passino C; Clerico A
    Clin Chem Lab Med; 2012 Nov; 50(11):2009-17. PubMed ID: 23089537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children.
    McWilliam SJ; Antoine DJ; Sabbisetti V; Pearce RE; Jorgensen AL; Lin Y; Leeder JS; Bonventre JV; Smyth RL; Pirmohamed M
    Biomark Med; 2014; 8(10):1189-97. PubMed ID: 24661102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia.
    Tomczak J; Wasilewska A; Milewski R
    Pediatr Nephrol; 2013 Sep; 28(9):1863-9. PubMed ID: 23673972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
    Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
    Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
    Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.